{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:31:39Z","timestamp":1790094699288,"version":"4.0.1"},"reference-count":36,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,3,29]],"date-time":"2005-03-29T00:00:00Z","timestamp":1112054400000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["APMIS"],"published-print":{"date-parts":[[2005,3]]},"abstract":"<jats:p>The complement system is part of the host defence response. However, considerable evidence suggests that complement plays an important role in the pathophysiology of ischemic heart disease. The aim of this study was to evaluate complement activation in patients with all forms of acute coronary syndromes (ACS) and to examine the relationship between the degree of complement activation and myocardial injury. The study population included 152 subjects (26 females): 82 with ACS (35 acute myocardial infarction (AMI), 22 non\u2010Q wave MI (NQMI), 25 unstable angina (UAP)) (Group A), 35 stable angina (SA) (Group B), and 35 healty control subjects (Group C). Complement 3 (C3), Complement 4 (C4), C\u2010reactive protein (CRP), troponin I (TnI) as well as creatine kinase MB (CK\u2010MB) were evaluated. Patients' blood samples were taken on admission (day 1) and after 2, 3 and 7 days in group A. However, only one measurement was performed in the groups B and C. Plasma C3 and C4 peak levels were significantly higher in patients with AMI (141\u00b129 and 35\u00b111 mg\/dl) and NQMI (136\u00b113 and 35\u00b17 mg\/dl) than in patients with SA (128\u00b114 and 27\u00b110 mg\/dl) and the control subjects (114\u00b122 and 22\u00b17 mg\/dl) (p&lt;0.03). Also, C3 and C4 serum levels in patients with SA and UAP (126\u00b116 and 31\u00b17 mg\/dl) were significantly higher than those in control subjects (p&lt;0.01, p&lt;0.03, respectively). At 1\u2010week follow\u2010up, there were no significant differences between the plasma levels of C3 and C4 in patients with UAP (p&gt;0.05). However, plasma levels of C3 and C4 were significantly different between days in patients with AMI and NQMI (p&lt;0.0001). Plasma C3 and C4 levels in ACS showed a relationship with peak CK\u2010MB and Tn I levels (p&lt;0.01). Plasma CRP level in ACS showed positive correlation with C3 (p&lt;0.01) and C4 (p&lt;0.001). In this study, we determined that plasma C3 and C4 levels were elevated in ACS and SA. Although C3 and C4 were higher in ACS and SA, the systemic levels of inflammatory markers in patients with SA and UAP were lower than those found in the AMI and NQMI groups. The relationship between C3, C4 levels and ACS further suggests that the complement activation is related to necrosis within the myocardium.<\/jats:p>","DOI":"10.1111\/j.1600-0463.2005.apm1130303.x","type":"journal-article","created":{"date-parts":[[2005,3,29]],"date-time":"2005-03-29T15:38:26Z","timestamp":1112110706000},"page":"167-174","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Complement activation in acute coronary syndromes"],"prefix":"10.1111","volume":"113","author":[{"given":"KENAN","family":"ILTUMUR","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AZIZ","family":"KARABULUT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00dcLTEN","family":"TOPRAK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NIZAMETTIN","family":"TOPRAK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,3,29]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901143400207"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.80.1.14"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00381-0"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199704033361401"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.57.070188.001541"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200115090-00004"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(98)01417-0"},{"key":"e_1_2_6_9_2","first-page":"839","article-title":"Inflammation in cardiovascular disease: cart, horse or both?","volume":"98","author":"Tracy R","year":"1998","journal-title":"Circulation"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.22.2259"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2002.3191"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.80.2.410"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)03019-X"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/28.9.1301"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/28.4.437"},{"key":"e_1_2_6_16_2","first-page":"448","article-title":"Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs","volume":"268","author":"Amsterdam EA","year":"1995","journal-title":"Am J Physiol"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65026-2"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.133.4.885"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-5769(00)00044-8"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108145"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1182\/blood.V76.2.361.361","article-title":"Consecutive enzyme cascades: complement activation at the cell surface triggers increased tissue factor activity","volume":"76","author":"Carson SD","year":"1990","journal-title":"Blood"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.2000.278.5.F747"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01907053"},{"key":"e_1_2_6_24_2","first-page":"389","article-title":"Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction","volume":"2","author":"Zeitler H","year":"1997","journal-title":"Eur J Med Res"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.81.1.156"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01899-5"},{"key":"e_1_2_6_27_2","first-page":"515","article-title":"Immune response in acute coronary syndromes","volume":"51","author":"Jan V","year":"1999","journal-title":"Indian Heart J"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0463.2000.d01-15.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(88)90204-3"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(85)90030-9"},{"key":"e_1_2_6_31_2","first-page":"28","article-title":"Role of complement system in atherosclerosis","volume":"32","author":"Hergenc G","year":"2004","journal-title":"T\u00fcrk Kardiyol Dern Ar\u00b0"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.19.10.2348"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.18.9.1376"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.2.237"},{"key":"e_1_2_6_35_2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4049\/jimmunol.157.1.473","article-title":"CRP\u2010mediated activation of complement in vivo: assessment by measuring circulating complement\u2010C\u2010reactive protein complexes","volume":"157","author":"Wolbink GJ","year":"1996","journal-title":"J Immunol"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1253\/jcj.53.1017"},{"key":"e_1_2_6_37_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000463029","article-title":"Acute phase reactants and complement activation in patients with acute myocardial infarction","volume":"5","author":"Mollnes TE","year":"1988","journal-title":"Complement"}],"container-title":["APMIS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0463.2005.apm1130303.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0463.2005.apm1130303.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T09:57:45Z","timestamp":1697018265000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0463.2005.apm1130303.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1111\/j.1600-0463.2005.apm1130303.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0463.2005.apm1130303.x","archive":["Portico"],"relation":{},"ISSN":["0903-4641","1600-0463"],"issn-type":[{"value":"0903-4641","type":"print"},{"value":"1600-0463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"2005-03-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}